Page 52 - GTM-3-3

Global Translational Medicine Ocular changes in Alzheimer’s disease

a mouse model of Alzheimer’s disease: A longitudinal doi: 10.1111/j.1469-7580.2005.00395.x
multimodal in vivo study. Alzheimers Res Ther. 2019;11:90.
57. He JT, Zhao X, Xu L, Mao CY. Vascular risk factors and
doi: 10.1186/s13195-019-0542-8 Alzheimer’s disease: Blood-brain barrier disruption,
metabolic syndromes, and molecular links. J Alzheimers Dis.
48. Bevan RJ, Hughes TR, Williams PA, Good MA, Morgan BP, 2020;73(1):39-58.
Morgan JE. Retinal ganglion cell degeneration correlates
with hippocampal spine loss in experimental Alzheimer’s doi: 10.3233/JAD-190764
disease. Acta Neuropathol Commun. 2020;8(1):216. 58. Farkas E, Luiten PGM. Cerebral microvascular pathology
doi: 10.1186/s40478-020-01094-2 in aging and Alzheimer’s disease. Prog Neurobiol.
2001;64(6):575-611.
49. Kesler A, Vakhapova V, Korczyn AD, Naftaliev E,
Neudorfer M. Retinal thickness in patients with mild doi: 10.1016/S0301-0082(00)00068-X
cognitive impairment and Alzheimer’s disease. Clin Neurol 59. Fischer VW, Siddiqi A, Yusufaly Y. Altered angioarchitecture
Neurosurg. 2011;113(7):523-526. in selected areas of brains with Alzheimer’s disease. Acta
doi: 10.1016/j.clineuro.2011.02.014 Neuropathol. 1990;79(6):672-679.
50. Parisi V, Restuccia R, Fattapposta F, Mina C, Bucci MG, doi: 10.1007/BF00294246
Pierelli F. Morphological and functional retinal impairment 60. Dorr A, Sahota B, Chinta LV, et al. Amyloid-β-dependent
in Alzheimer’s disease patients. Clin Neurophysiol. compromise of microvascular structure and function in
2001;112(10):1860-1867. a model of Alzheimer’s disease. Brain. 2012;135(Pt 10):
doi: 10.1016/S1388-2457(01)00620-4 3039-3050.
51. Georgevsky D, Retsas S, Raoufi N, Shimoni O, Golzan SM. doi: 10.1093/brain/aws243
A longitudinal assessment of retinal function and structure 61. Ma Q, Zhao Z, Sagare AP, et al. Blood-brain barrier-
in the APP/PS1 transgenic mouse model of Alzheimer’s associated pericytes internalize and clear aggregated
disease. Transl Neurodegener. 2019;8:30. amyloid-β42 by LRP1-dependent apolipoprotein E isoform-
specific mechanism. Mol Neurodegener. 2018;13(1):57.
doi: 10.1186/s40035-019-0170-z
doi: 10.1186/s13024-018-0286-0
52. Mutlu U, Colijn JM, Ikram MA, et al. Association of retinal
neurodegeneration on optical coherence tomography 62. Halliday MR, Rege SV, Ma Q, et al. Accelerated pericyte
with dementia: A population-based study. JAMA Neurol. degeneration and blood-brain barrier breakdown in
2018;75(10):1256-1263. apolipoprotein E4 carriers with Alzheimer’s disease. J Cereb
Blood Flow Metab. 2016;36(1):216-227.
doi: 10.1001/jamaneurol.2018.1563
doi: 10.1038/jcbfm.2015.44
53. Iseri PK, Altinaş Ö, Tokay T, Yüksel N. Relationship
between cognitive impairment and retinal morphological 63. Shibata M, Yamada S, Kumar SR, et al. Clearance of
and visual functional abnormalities in Alzheimer disease. Alzheimer’s amyloid-ss(1-40) peptide from brain by LDL
J Neuroophthalmol. 2006;26(1):18-24. receptor-related protein-1 at the blood-brain barrier. J Clin
Invest. 2000;106(12):1489-1499.
doi: 10.1097/01.wno.0000204645.56873.26
doi: 10.1172/JCI10498
54. Fujino Y, DeLucia MW, Davies P, Dickson DW. Ballooned
neurones in the limbic lobe are associated with Alzheimer 64. Cheung CY, Ong YT, Ikram MK, et al. Microvascular
type pathology and lack diagnostic specificity. Neuropathol network alterations in the retina of patients with Alzheimer’s
Appl Neurobiol. 2004;30(6):676-682. disease. Alzheimers Dement. 2014;10(2):135-142.
doi: 10.1111/j.1365-2990.2004.00593.x doi: 10.1016/j.jalz.2013.06.009
55. Reichenbach A, Wurm A, Pannicke T, Iandiev I, 65. Shi H, Koronyo Y, Fuchs DT, et al. Retinal capillary
Wiedemann P, Bringmann A. Müller cells as players in degeneration and blood-retinal barrier disruption in murine
retinal degeneration and edema. Graefes Arch Clin Exp models of Alzheimer’s disease. Acta Neuropathol Commun.
Ophthalmol. 2007;245(5):627-636. 2020;8(1):202.
doi: 10.1007/s00417-006-0516-y doi: 10.1186/s40478-020-01076-4
66. Nazari HK, Karimaghaei C, van der Merwe R, et al. Age
56. Patton N, Aslam T, MacGillivray T, Pattie A, Deary IJ,
Dhillon B. Retinal vascular image analysis as a potential dependence of retinal vascular plexus attenuation in the
screening tool for cerebrovascular disease: A rationale triple transgenic mouse model of Alzheimer’s disease. Exp
based on homology between cerebral and retinal Eye Res. 2022;214:108879.
microvasculatures. J Anat. 2005;206(4):319-348. doi: 10.1016/j.exer.2021.108879

Volume 3 Issue 3 (2024) 13 doi: 10.36922/gtm.4094